Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | GLA | P06280 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 3/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | PGR | P06401 | 3/20 | 0.37 |
| ▸ | ESR1 | P03372 | 2/20 | 0.37 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.37 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.37 |
| ▸ | AR | P10275 | 1/20 | 0.37 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.37 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.37 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.34 |
| ▸ | ELANE | P08246 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18433275 | 0.89 | LMNA (0.38) | LMNAGLATSHRKDM4EALDH1A1 | |
| SCHEMBL22007000 | 0.84 | LMNA (0.39) | LMNAGLATSHRKDM4EALDH1A1 | |
| SCHEMBL14070609 | 0.81 | MAPK1 (0.31) | POLBMAPTPKMPTGS2 | |
| SCHEMBL16247813 | 0.78 | ALDH1A1 (0.30) | TSHRALDH1A1 | |
| SCHEMBL2758566 | 0.78 | GLA (0.33) | LMNAGLATSHRKDM4EALDH1A1 | |
| SCHEMBL2533106 | 0.77 | LMNA (0.38) | LMNAGLATSHRKDM4EALDH1A1 | |
| SCHEMBL25113 | 0.77 | — | — | |
| SCHEMBL6639439 | 0.77 | GLA (0.38) | LMNAGLAALDH1A1PGRESR1 | |
| SCHEMBL7338970 | 0.77 | GLA (0.32) | LMNAGLATSHRKDM4EALDH1A1 | |
| SCHEMBL31648648 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11518726-B2 | Synthesis of bicyclo[2.2.2]octane derivatives | EASTMAN CHEMICAL COMPANY (US) | 2022-12-06 | — | — | US | disclosed |
| CN-109843846-B | Synthesis of bicyclo [2.2.2] octane | 伊士曼化工公司 | 2022-07-05 | — | — | CN | disclosed |
| EP-3529230-B1 | SYNTHESIS OF BICYCLO(2.2.2)OCTANES | EASTMAN CHEM CO (US) | 2020-09-30 | — | — | EP | disclosed |
| US-10633315-B2 | Synthesis of bicyclo[2.2.2]octanes | EASTMAN CHEMICAL COMPANY (US) | 2020-04-28 | — | — | US | disclosed |
| US-20200039906-A1 | SYNTHESIS OF BICYCLO[2.2.2]OCTANES | EASTMAN CHEMICAL COMPANY (US) | 2020-02-06 | — | — | US | disclosed |
| WO-2019075004-A1 | SYNTHESIS OF BICYCLO[2.2.2]OCTANE DERIVATIVES | EASTMAN CHEMICAL COMPANY (US) | 2019-04-18 | — | — | WO | disclosed |
| WO-2018075301-A1 | SYNTHESIS OF BICYCLO(2.2.2)OCTANES | EASTMAN CHEMICAL COMPANY (US) | 2018-04-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200039906-A1 | SYNTHESIS OF BICYCLO[2.2.2]OCTANES | PPOX, ODC1, AOC2 | LMNA 4470/4885GLA 4074/4885TSHR 3951/4885 |
| US-10633315-B2 | Synthesis of bicyclo[2.2.2]octanes | PPOX, ODC1, AOC2 | LMNA 4470/4885GLA 4074/4885TSHR 3951/4885 |
| US-11518726-B2 | Synthesis of bicyclo[2.2.2]octane derivatives | SCO2, AOC2, ODC1 | LMNA 3184/4885GLA 3697/4885TSHR 4297/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.